1[1]Brown GC, Tasman WS, Benson WE, et al. Reoperation following diabetic vitrectomy[J]. Arch Ophthalmol 1992;110∶506-510.
2[2]Lean JS, Leaver PK, Cooling RL, et al. Management of complex retinal detachments by vitrectomy and fluid/silicone exchange[J]. Trans Ophthalmol Soc UK 1982;102∶203-205.
3[3]Brourman ND, Blumenkeanz MS, Cox MS, et al. Silicone oil for the treatment of severe proliferative diabetic retinopathy[J]. Ophthalmology 1989;96∶759-764.
4[4]Steal DHW, Weir P,James CR. Silicone assisted, argon laser confinement of recurrent proliferative vitreoretinopathy related retinal detachment. A technique to allow silicone oil removal in problem eyes[J]. Br J Ophthalmol 1997;81∶765-770.
5[5]Yeo JH, Glaser BM, Michels RG.Silicone oil in the treatment of complicated retinal detachments.[J].Ophthalmology 1987;94∶1109-1113.
6[6]McCuen BW Ⅱ, de Juan E Jr, Machemer R.Silicone oil in vitreoretinal surgery part 1:surgical techniques[J]. Retina 1985;5∶189-197.
7[7]Hutton WL, Fuller DG.Silicone oil in treatment of retinal disease[J]. Ophthalmol Clin North Am 1994;7(1)∶88-99.
8[8]de Juan E Jr, Hardy M, Hatche Ⅱ DL, et al. The effect of intraocular silicone oil on anterior chamber oxyen pressure in cats[J]. Arch Ophthalmol 1986;104∶1063-1064.
9[9]McCuen BW Ⅱ,Rinkoff JS.Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomy[J]. Arch Ophthalmol 1989;107∶677-678.
10[10]Gonvers M. Temporary silicone oil tamponade in the management of retinal detachment with proliferative vitreoretinopathy[J]. Am J Ophthalmol 1985;100∶239.
4Mazurina NK.The current data on the proliferative process in diabetic retinopathy[J].Vestn Ofalmol, 1999,115 ( 3 ) : 37.
5Nakazawa M, kimizuka Y, Watabe T, et al.Visual outcome after vitrectomy for diabetic retinopathy.A five-year follow up [J].Acta Ophthalmol(Copenh), 1993,71 (2) : 219-223.
6Smiddy WE,Feuer W,lrvine WD,Vitrectomy for complications of proliferative diabetic retinopathy.Functional outcomes[J].Ophthalmology, 1995,102: 1688-1695.
